AZmed, a European MedTech company founded in 2018, is at the forefront of integrating AI solutions into medical imaging. Known for its slogan, "Your AI Partner for Medical Imaging," AZmed has developed the Rayvolve® AI Suite for X-rays and the Rayscan® line for CT imaging. The company focuses on enhancing diagnostic confidence, improving workflow efficiency, and strengthening operational performance in clinical settings.
The company's products are operational in over 2,500 healthcare facilities across 55+ countries and are engineered to integrate smoothly with existing radiology workflows, including PACS/RIS systems. The Rayvolve® AI Suite offers a range of solutions such as AZtrauma, AZchest, AZmeasure, and AZboneage. In 2025, AZmed broadened its offerings with AZnod, a CE-marked CT solution for lung nodule detection.
AZmed recently secured a €15.00M Series A investment in February 2024 from notable firms including Techstars, Maison Capital, and Teampact Ventures. Headquartered in France, the company continues to work closely with radiologists, ensuring its AI solutions meet the rising demand in healthcare while maintaining quality and efficiency.